Skip to main content
TipRanks
Go Ultimate75% OFF

ADM Tronics Un (ADMT) AI Stock Analysis

19 Followers
ADMT

ADM Tronics Un

(Other OTC:ADMT)

Select Model
Rating:49Neutral
Price Target:$0.11â–¼(-10.08% Downside)
Action:reiterated
Date:11/12/26

The score is held down primarily by weak financial performance (revenue contraction, continued losses, and negative operating/free cash flow) and a loss-based valuation signal (negative P/E). These negatives are partially offset by strong technical momentum (price above key moving averages with a positive MACD) and a constructive corporate event (private placement funding and board reconstitution).

Positive Factors
Diversified technology and manufacturing baseA combination of proprietary products, medical electronics, specialty chemicals, engineering, and contract manufacturing gives ADM Tronics multiple routes to serve healthcare and industrial customers. This breadth can support resilience and create opportunities to build recurring customer relationships over the next several quarters.
Negative Factors
Material revenue contractionA roughly 19% TTM revenue decline signals weakening demand or execution across the current business base. Continued contraction would reduce scale, make fixed costs harder to absorb, and limit the company’s ability to convert its technology and manufacturing capabilities into sustainable growth.

ADM Tronics Un (ADMT) vs. SPDR S&P 500 ETF (SPY)

-75%-50%-25%0%25%50%ADMT+16.67%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$8.08M
Dividend Yield
―
Average Volume (3M)
50.06K
Price to Earnings (P/E)
-20.6
Beta (1Y)
-0.13
Revenue Growth
-2.21%
EPS Growth
-490.00%
Country
US
Employees
30
Sector
General
Sector Strength
55
Industry
Medical - Devices

ADM Tronics Un Business Overview & Revenue Model

Company Description

ADM Tronics Unlimited, Inc. (ADMT), established in 1969 and headquartered in Northvale, New Jersey, is a company that develops, manufactures, and markets electronic solutions. Its products are primarily designed for non-invasive medical applications,...

ADM Tronics Un Financial Statement Overview

Summary

Financials are weak: TTM revenue fell ~19% and the company remains unprofitable with negative operating income and net loss. Cash flow is a major drag with negative TTM operating cash flow and free cash flow, increasing funding risk. The balance sheet is workable (positive equity) but leverage has risen (debt-to-equity ~1.0), reducing flexibility if results don’t improve.

Income Statement

34Negative

Balance Sheet

46Neutral

Cash Flow

28Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue3.35M3.35M3.20M2.97M3.68M3.21M
Gross Profit1.36M1.36M1.40M1.12M1.66M1.25M
EBITDA59.65K-60.35K12.29K-732.58K80.35K-1.02M
Net Income-100.37K-100.37K-123.06K-877.22K-96.32K-1.38M
Balance Sheet
Total Assets1.83M1.83M2.13M2.14M3.09M3.35M
Cash, Cash Equivalents and Short-Term Investments255.73K255.73K382.97K537.04K1.00M1.04M
Total Debt741.26K741.26K846.86K918.33K752.69K1.02M
Total Liabilities1.26M1.26M1.46M1.45M1.52M1.98M
Stockholders Equity570.97K570.97K671.35K692.39K1.57M1.37M
Cash Flow
Free Cash Flow-124.06K-124.06K9,978-724.40K125.02K-574.95K
Operating Cash Flow-124.06K-124.06K9,978-709.89K125.02K-574.95K
Investing Cash Flow00-225.75K-14.52K00
Financing Cash Flow-3,180-3,18061.70K257.71K-258.56K66.50K

ADM Tronics Un Technical Analysis

Technical Analysis SentimentPositive
Last Price0.12

Price Trends

50DMA0.06Positive
100DMA0.05Positive
200DMA0.07Positive

Market Momentum

MACD0.02Negative
RSI70.20Negative
STOCH70.43Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADMT, the sentiment is Positive. The current price of 0.12 is above the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.06, and above the 200-day MA of 0.07, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 70.20 is Negative, neither overbought nor oversold. The STOCH value of 70.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ADMT.

ADM Tronics Un Risk Analysis

ADM Tronics Un disclosed 17 risk factors in its most recent earnings report. ADM Tronics Un reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

ADM Tronics Un Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

ADMT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
ADMTADMT49Neutral$8.08M-20.60-56.20%―-2.21%-490.00%
MOVEMOVE47Neutral$174.95M-0.35-9.44%―1767.40%19.21%
AEMDAEMD44Neutral$8.49M-0.50-141.22%――90.69%
AMIXAMIX40Underperform$2.80M-0.07-191.88%――81.59%

* General Sector Average

Performance Comparison

0%100%200%ADMTAEMDMOVEAMIXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
ADMT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
ADMTADM Tronics Un 0.120.0221.43%
AEMDAethlon5.29-14.96-73.88%
MOVECorvex, Inc.4.47-3.00-40.16%
AMIXAutonomix Medical, Inc.1.37-22.78-94.33%

ADM Tronics Un Corporate Events

Business Operations and StrategyExecutive/Board ChangesPrivate Placements and Financing

ADM Tronics Un launches strategic private placement and board overhaul

Positive
Oct 30, 2026

ADM Tronics Unlimited, Inc., a long-established technology company in medical electronic devices, specialty water-based chemicals and FDA-registered engineering and contract manufacturing, is based in Northvale, N.J. and serves healthcare and industr...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 12, 2026